PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
FULC vs. MELI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

FULC vs. MELI

Last updated May 12, 2025

Compare and contrast key facts about Fulcrum Therapeutics, Inc. (FULC) and MercadoLibre, Inc. (MELI).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FULC or MELI.

Correlation

The correlation between FULC and MELI is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

FULC vs. MELI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulcrum Therapeutics, Inc. (FULC) and MercadoLibre, Inc. (MELI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

FULC:

95.33%

MELI:

39.95%

Max Drawdown

FULC:

-11.52%

MELI:

-89.49%

Current Drawdown

FULC:

-6.28%

MELI:

0.00%

Fundamentals

Market Cap

FULC:

$289.87M

MELI:

$124.21B

EPS

FULC:

-$0.01

MELI:

$40.67

PS Ratio

FULC:

3.62

MELI:

5.98

PB Ratio

FULC:

1.20

MELI:

26.36

Total Revenue (TTM)

FULC:

$80.00M

MELI:

$16.44B

Gross Profit (TTM)

FULC:

$62.74M

MELI:

$7.55B

EBITDA (TTM)

FULC:

-$6.35M

MELI:

$2.56B

Returns By Period

FULC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

MELI

YTD

44.08%

1M

22.69%

6M

30.88%

1Y

44.63%

5Y*

26.43%

10Y*

32.75%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

FULC vs. MELI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
FULC
The Risk-Adjusted Performance Rank of FULC is 4141
Overall Rank
The Sharpe Ratio Rank of FULC is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of FULC is 4848
Sortino Ratio Rank
The Omega Ratio Rank of FULC is 5050
Omega Ratio Rank
The Calmar Ratio Rank of FULC is 3232
Calmar Ratio Rank
The Martin Ratio Rank of FULC is 4040
Martin Ratio Rank
MELI
The Risk-Adjusted Performance Rank of MELI is 8585
Overall Rank
The Sharpe Ratio Rank of MELI is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of MELI is 8181
Sortino Ratio Rank
The Omega Ratio Rank of MELI is 8080
Omega Ratio Rank
The Calmar Ratio Rank of MELI is 9292
Calmar Ratio Rank
The Martin Ratio Rank of MELI is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FULC vs. MELI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and MercadoLibre, Inc. (MELI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data
No data

Loading data...

Dividends

FULC vs. MELI - Dividend Comparison

Neither FULC nor MELI has paid dividends to shareholders.

TTM20242023202220212020201920182017201620152014
FULC
Fulcrum Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MELI
MercadoLibre, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.19%0.38%0.36%0.52%

Drawdowns

FULC vs. MELI - Drawdown Comparison

The maximum FULC drawdown since its inception was -11.52%, smaller than the maximum MELI drawdown of -89.49%. Use the drawdown chart below to compare losses from any high point for FULC and MELI. For additional features, visit the drawdowns tool.

Loading data...

Volatility

FULC vs. MELI - Volatility Comparison

Loading data...

Financials

FULC vs. MELI - Financials Comparison

This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and MercadoLibre, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.001.00B2.00B3.00B4.00B5.00B6.00B202120222023202420250
6.06B
(FULC) Total Revenue
(MELI) Total Revenue
Values in USD except per share items